Phase II trial of low-dose intranasal testosterone [TBS 2; Tefina] in patients with anorgasmia: the Vibrotactile Stimulation Study.
Phase of Trial: Phase II
Latest Information Update: 15 Feb 2012
At a glance
- Drugs Testosterone (Primary)
- Indications Anorgasmia
- Focus Pharmacokinetics; Therapeutic Use
- Acronyms VTS
- 15 Feb 2012 Primary endpoint 'Sexual-satisfaction' (achievement of orgasm) has been met.
- 14 Feb 2012 Results published in a Trimel Pharmaceuticals Corporation media release.
- 19 Dec 2011 Final results will be presented at a Trimel R&D Event in February 2012.